1. Home
  2. WGS vs SII Comparison

WGS vs SII Comparison

Compare WGS & SII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$45.89

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Logo Sprott Inc.

SII

Sprott Inc.

N/A

Current Price

$93.11

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WGS
SII
Founded
2017
2008
Country
United States
Canada
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Finance: Consumer Services
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
WGS
SII
Price
$45.89
$93.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$82.00
★ $130.99
AVG Volume (30 Days)
★ 1.1M
114.5K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
★ 1.77%
EPS Growth
★ 62.37
N/A
EPS
N/A
★ N/A
Revenue
★ $427,539,000.00
N/A
Revenue This Year
$11.40
$42.44
Revenue Next Year
$19.61
N/A
P/E Ratio
★ N/A
$63.42
Revenue Growth
★ 39.97
N/A
52 Week Low
$32.21
$81.50
52 Week High
$170.87
$169.63

Technical Indicators

Market Signals
Indicator
WGS
SII
Relative Strength Index (RSI) 33.81 27.28
Support Level $32.21 N/A
Resistance Level $72.65 $109.99
Average True Range (ATR) 5.39 4.28
MACD -0.98 -1.43
Stochastic Oscillator 4.82 1.13

Price Performance

Historical Comparison
WGS
SII

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About SII Sprott Inc.

Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.

Share on Social Networks: